Could molecular assessment of calcium metabolism be a useful tool to early screen patients at risk for pre-eclampsia complicated pregnancy? Proposal and rationale

Clinical Chemistry and Laboratory Medicine

Volumn 53, Issue 7, 2015, Pages 975-979

  Gizzo, Salvatore ^a   Noventa, Marco ^a   Di Gangi, Stefania ^a   Saccardi, Carlo ^a   Cosmi, Erich ^a   Nardelli, Giovanni Battista ^a   Plebani, Mario ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Bone metabolism; calcium supplementation; pre eclampsia; pregnancy outcome; serum biochemical profile

Indexed keywords

CALCIUM;

CALCIUM HOMEOSTASIS; CALCIUM INTAKE; CALCIUM METABOLISM; CLINICAL ASSESSMENT TOOL; COST; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MINERAL SUPPLEMENTATION; PREECLAMPSIA; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; EARLY DIAGNOSIS; EVIDENCE BASED MEDICINE; METABOLISM; PRE-ECLAMPSIA; PREGNANCY; RISK;

CALCIUM; EARLY DIAGNOSIS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; RISK;

EID: 84930805111     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2014-0693     Document Type: Review

References (32)

1. Hofmeyr GJ, Lawrie TA, Atallah AN, Duley L, Torloni MR. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev 2014;6:CD001059.
2. Savaj S, Vaziri N. An overview of recent advances in pathogenesis and diagnosis of preeclampsia. Iran J Kidney Dis 2012;6:334-8.
3. Villar J, Abalos E, Nardin JM, Merialdi M, Carroli G. Strategies to prevent and treat preeclampsia: evidence from randomized controlled trials. Semin Nephrol 2004;24:607-15.
4. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013;34:2159-219.
5. Carroli G, Duley L, Belizán JM, Villar J. Calcium supplementation during pregnancy: a systematic review of randomised controlled trials. Br J Obstet Gynaecol 1994;101:753-8.
6. Repke JT, Villar J. Pregnancy-induced hypertension and low birth weight: the role of calcium. Am J Clin Nutr 1991;54:237S-241S.
7. Powers RW, Catov JM, Bodnar LM, Gallaher MJ, Lain KY, Roberts JM. Evidence of endothelial dysfunction in preeclampsia and risk of adverse pregnancy outcome. Reprod Sci 2008;15:374-81.
8. Lockwood CJ, Yen CF, Basar M, Kayisli UA, Martel M, Buhimschi I, et al. Preeclampsia-related inflammatory cytokines regulate interleukin-6 expression in human decidual cells. Am J Pathol 2008;172:1571-9.
9. Yu CK, Smith GC, Papageorghiou AT, Cacho AM, Nicolaides KH. An integrated model for the prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women. Am J Obstet Gynecol 2005;193:429-36.
10. Cnossen JS, Morris RK, ter Riet G, Mol BW, van der Post JA, Coomarasamy A, et al. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. Can Med Assoc J 2008;178:701-11.
11. Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 2010;116:402-14.
12. Velauthar L, Plana MN, Kalidindi M, Zamora J, Thilaganathan B, Illanes SE, et al. Uterine artery Doppler in the first trimester as a risk factor for adverse pregnancy outcomes: a metaanalysis involving 55, 974 women. Ultrasound Obstet Gynecol 2014;43:500-7.
13. Goetzinger KR, Zhong Y, Cahill AG, Odibo L, Macones GA, Odibo AO. Efficiency of first-trimester uterine artery Doppler, a-disintegrin and metalloprotease 12, pregnancy-associated plasma protein a, and maternal characteristics in the prediction of preeclampsia. J Ultrasound Med 2013;32:1593-600.
14. Meads CA, Cnossen JS, Meher S, Juarez-Garcia A, ter Riet G, Duley L, et al. Methods of prediction and prevention of preeclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling. Health Technol Assess 2008;12:iii-iv, 1-270.
15. Makrides M, Duley L, Olsen SF. Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction. Cochrane Database Syst Rev 2006;3:CD003402.
16. Basaran A, Basaran M, Topatan B. Combined vitamin C and E supplementation for the prevention of preeclampsia: a systematic review and meta-analysis. Obstet Gynecol Surv 2010;65:653-67.
17. Patrelli TS, Dall'asta A, Gizzo S, Pedrazzi G, Piantelli G, Jasonni VM, et al. Calcium supplementation and prevention of preeclampsia: a meta-analysis. J Matern Fetal Neonatal Med 2012;25:2570-4.
18. Imdad A, Bhutta ZA. Effects of calcium supplementation during pregnancy on maternal, fetal and birth outcomes. Paediatr Perinat Epidemiol 2012;26:138-52.
19. Richards DG, Lindow SW, Carrara H, Knight R, Haswell SJ, Van der Spuy ZM. A comparison of maternal calcium and magnesium levels in pre-eclamptic and normotensive pregnancies: an observational case-control study. Br J Obstet Gynaecol 2014;121:327-36.
20. Kim J, Kim YJ, Lee R, Moon JH, Jo I. Serum levels of zinc, calcium, and iron are associated with the risk of preeclampsia in pregnant women. Nutr Res 2012;32:764-9.
21. Hofmeyr G, Belizán J, von Dadelszen P, Calcium and Pre-eclampsia (CAP) Study Group. Low-dose calcium supplementation for preventing pre-eclampsia: a systematic review and commentary. Br J Obstet Gynaecol 2014;121:951-7.
22. Carroli G, Merialdi M, Wojdyla D, Abalos E, Campodonico L, Yao SE, et al. Effects of calcium supplementation on uteroplacental and fetoplacental blood flow in low-calcium-intake mothers: a randomized controlled trial. Am J Obstet Gynecol 2010;202:45.e1-9.
23. Jain S, Sharma P, Kulshreshtha S, Mohan G, Singh S. The role of calcium, magnesium, and zinc in pre-eclampsia. Biol Trace Elem Res 2010;133:162-70.
24. Yang H, Kim TH, An BS, Choi KC, Lee HH, Kim JM, et al. Differential expression of calcium transport channels in placenta primary cells and tissues derived from preeclamptic placenta. Mol Cell Endocrinol 2013;367:21-30.
25. Tomaschitz A, Pilz S. Interplay between sodium and calcium regulatory hormones: a clinically relevant research field. Hypertension 2014;63:212-4.
26. Kumar A, Devi SG, Prasad S, Kapoor S, Sharma S. Bone turnover in preeclampsia-complicated pregnancy in North Indian women. J Obstet Gynaecol Res 2012;38:172-9.
27. Shaarawy M, Zaki S, Ramzi AM, Salem ME, El-Minawi AM. Feto-maternal bone remodeling in normal pregnancy and preeclampsia. J Soc Gynecol Investig 2005;12:343-8.
28. Anim-Nyame N, Sooranna SR, Jones J, Alaghband-Zadeh J, Steer PJ, Johnson MR. A longitudinal study of biochemical markers of bone turnover during normal pregnancy and pregnancies complicated by pre-eclampsia. Br J Obstet Gynaecol 2002;109:708-13.
29. Mozzanega B, Gizzo S, Bernardi D, Salmaso L, Patrelli TS, Mioni R, et al. Cyclic variations of bone resorption mediators and markers in the different phases of the menstrual cycle. J Bone Miner Metab 2013;31:461-7.
30. Gizzo S, Noventa M, Saccardi C, Paccagnella G, Patrelli TS, Cosmi E, et al. Twin pregnancy after kidney transplantation: what's on? A case report and review of literature. J Matern Fetal Neonatal Med 2014. [Epub ahead of print 2014 Feb 3]. PubMed PMID: 24397798.
31. Shen P, Gong Y, Wang T, Chen Y, Jia J, Ni S, et al. Expression of osteoprotegerin in placenta and its association with preeclampsia. PLoS One 2012;7:e44340.
32. Dorota DK, Bogdan KG, Mieczyslaw G, Bozena LG, Jan O. The concentrations of markers of bone turnover in normal pregnancy and preeclampsia. Hypertens Pregnancy 2012;31: 166-76.